E-cadherin (CDH-1 ) polymorphisms associate with airway remodeling, inflammation and FEV1 decline in asthma patients using inhaled corticosteroids (ICS) Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases Year: 2010
Genetic and environmental interaction in allergy and asthma Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007
Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2 -agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 35s Year: 2003
Inhaled corticosteroids and growth of airway function in asthmatic children Source: Eur Respir J 2004; 23: 861-868 Year: 2004
ADRB2 Gly16Arg polymorphism, asthma control and lung function decline Source: Eur Respir J 2011; 38: 1029-1035 Year: 2011
Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness Source: Eur Respir J 2009; 33: 1287-1294 Year: 2009
Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Source: Eur Respir J 2006; 27: 172-187 Year: 2006
Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression Source: Eur Respir J 2001; 18: 139-145 Year: 2001
Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011
Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison Source: Eur Respir J 2007; 30: 653-661 Year: 2007
Meta-analysis of airway epithelium gene expression in asthma Source: Eur Respir J, 51 (5) 1701962; 10.1183/13993003.01962-2017 Year: 2018
Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002
Severe therapy resistant asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=312 Year: 2003
Osteopontin expression and relation to disease severity in human asthma Source: Eur Respir J 2011; 37: 331 Year: 2011
Association of AQP5 gene polymorphisms with osmotic airway hyperresponsiveness in asthma Source: International Congress 2019 – Genes and environment Year: 2019
Effects of intervention with high-dose inhaled corticosteroids on airway remodelling in diagnosed genetic variants of IL13 with asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010
Distinct epithelial gene expression phenotypes in childhood respiratory allergy Source: Eur Respir J 2012; 39: 1197-1205 Year: 2012
Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS) Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
ADAM33 SNPs are associated with airway hyperresponsiveness and airway inflammation in COPDSource: Eur Respir J 2005; 26: Suppl. 49, 3s Year: 2005
Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation Source: Eur Respir J, 54 (3) 1901088; 10.1183/13993003.01088-2019 Year: 2019